Affinity Asset Advisors, LLC Galapagos Nv Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$47.03 - $57.12 $940,600 - $1.14 Million
-20,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$68.86 - $83.34 $516,450 - $625,050
7,500 Added 60.0%
20,000 $1.39 Million
Q1 2021

May 14, 2021
BUY
$76.15 - $111.94 $951,875 - $1.4 Million
12,500 New
12,500 $964,000

Others Institutions Holding GLPG

# of Institutions
85
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email